$0.05 (1.26%)
Industry, Sector & symbol
Stock Exchange | NASDAQ Capital Market |
CEO | Mr. Eric K. Olson |
Industry | Medical - Devices |
Sector | Healthcare |
Current Symbol | SINT |
CUSIP | 829392307 |
CIK | 0001269026 |
Web | https://www.sintx.com |
Phone | 801 839 3500 |
Currency | USD |
Employees | 43 |
Country | US |
Liquidity
Debt-to-Equity Ratio | 0.02 |
Payout Ratio | 0.00 |
Current Ratio | 3.04 |
Quick Ratio | 2.82 |
Cash Ratio | 2.31 |
Sales & Book Value
Annual Sales | $2.63M |
Price / Sales | 1.66 |
Cash Flow | -12.57 |
Price / Cash Flow | -0.48 |
Price / Book | 0.64 |
Price Target and Rating
Average Stock Price Forecast | $ |
High Stock Price Forecast | $ |
Low Stock Price Forecast | $ |
Forecast Upside/Downside | % |
Consensus Rating | Sell |
Rating Score(0-5) | 2 |
Research Coverage | 1 Analysts |
Profitability
EPS (Most Recent Fiscal Year) | $-624.48 |
Trailing P/E Ratio | -0.31 |
PEG Ratio | -0.05 |
P/E Growth | -0.05 |
Net Income | $-8.26M |
Net Margin | -358.79% |
Pretax Margin | -358.79% |
Return on Equity | -140.68% |
Return on Assets | -103.07% |
Financials Score
AltmanZ Score | -36.78 |
Piotroski Score | 3.00 |
Working Capital | 4.25M |
Total Assets | 11.3M |
Ebit | -11.64M |
Market Cap | 5.38M |
Total Liabilities | 5.72M |
About Sintx Technologies, Inc. (NASDAQ:SINT) Stock
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. ...
2024-11-21 06:00:00
Salt Lake City, UT, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, announces the signing of a Joint Development Agreement (JDA) with NED Medical Inc., an innovative developer of oncology embolization therapy technologies. This collaboration aims to accelerate the development of advanced ceramic-based microspheres, a groundbreaking advancement in radiotherapeutic applications.
SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer
2024-11-19 06:00:00
Seasoned Healthcare Executive to Lead Strategic Growth Initiatives Salt Lake City, UT, Nov. 19, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, is pleased to announce the appointment of Gregg R. Honigblum as Chief Strategy Officer (CSO).
SINTX Technologies Announces Stock Repurchase Program
2024-11-18 06:00:00
Salt Lake City, UT , Nov. 18, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, today announced that its Board of Directors has authorized a stock repurchase program to buy back up to $500,000 of the company's outstanding common stock over the next several quarters which equates to about 20% of total outstanding shares. The repurchases will be conducted based on market conditions and other factors, reflecting SINTX's confidence in its strategic direction and commitment to enhancing shareholder value.
SINTX Technologies Provides Positive Strategic Business Update for Q3 2024
2024-11-14 06:00:00
Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, announced today a positive update on its recent strategic initiatives and financial performance, showcasing the Company's commitment to realigning its resources and achieving long-term growth.
2024-10-01 08:00:00
Salt Lake City, Utah, Oct. 01, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) an advanced materials company specializing in ceramics for biomedical, aerospace, and industrial applications, is pleased to announce two key executive promotions.
Frequently Asked Questions
What is the current Sintx Technologies, Inc. (SINT) stock price?
Sintx Technologies, Inc.(NASDAQ:SINT) stock price is $4.01 in the last trading session. During the trading session, SINT stock reached the peak price of $105.8 while $2.01 was the lowest point it dropped to. The percentage change in SINT stock occurred in the recent session was 1.26% while the dollar amount for the price change in SINT stock was $0.05.
SINT's industry and sector of operation?
The NASDAQ listed SINT is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of SINT?
Mr. Eric K. Olson
| President, Chief Executive Officer & Director
Ms. Ann Kutsch
| President of SINTX Technology Assessment & Transfer
Dr. Ryan Bock Ph.D.
| Chief Technology Officer
Ms. Gina Moss
| Director of Operations
|
How many employees does SINT have?
Number of SINT employees currently stands at 43. SINT operates from 1885 West 2100 South, Salt Lake City, UT 84119, US.
Link for SINT official website?
Official Website of SINT is: https://www.sintx.com
How do I contact SINT?
SINT could be contacted at phone #801 839 3500 and can also be accessed through its website. SINT operates from 1885 West 2100 South, Salt Lake City, UT 84119, US.
How many shares of SINT are traded daily?
The average number of SINT shares traded daily for last 3 months was 2.13M.
What is the market cap of SINT currently?
The market value of SINT currently stands at $5.38M with its latest stock price at $4.01